These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34671397)

  • 1. Machine-Learning-Based m5C Score for the Prognosis Diagnosis of Osteosarcoma.
    Zhang H; Xu P; Song Y
    J Oncol; 2021; 2021():1629318. PubMed ID: 34671397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
    Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
    Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the importance of m5c in the diagnosis and subtype classification of COPD using the GEO database.
    Wu J; Li X; Kong D; Zheng X; Du W; Zhang Y; Jiao Y; Li X
    Gene; 2024 Feb; 895():147987. PubMed ID: 37972696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Pan J; Huang Z; Xu Y
    Front Cell Dev Biol; 2021; 9():671821. PubMed ID: 34268304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
    Yan D; Xie Y; Huang L; Zhang Y; Gu R; Xie H; Huang X; Luo H
    J Cell Mol Med; 2023 Aug; 27(16):2398-2411. PubMed ID: 37408139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.
    Yun D; Yang Z; Zhang S; Yang H; Liu D; Grützmann R; Pilarsky C; Britzen-Laurent N
    Front Cell Dev Biol; 2022; 10():975684. PubMed ID: 36060802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma.
    Qian H; Lei T; Hu Y; Lei P
    Front Cell Dev Biol; 2021; 9():673827. PubMed ID: 33937273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
    Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
    Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies.
    Tan X; Cai Z; Chen G; Cai C; Chen J; Liang Y; Zhuo Y; Liu J; Huang L; Ouyang B; Wei Y; Jia Z; Deng J; Zhong W; Lu J
    Discov Oncol; 2023 May; 14(1):62. PubMed ID: 37155024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of 5-Methylcytosine Profiles of Messenger RNA in Human High-Grade Serous Ovarian Cancer by MeRIP Sequencing.
    Meng L; Zhang Q; Huang X
    Cancer Manag Res; 2021; 13():6005-6018. PubMed ID: 34377020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy.
    Wu S; Li M; Su R; Shen H; He Y; Zhou Y
    Front Surg; 2022; 9():948371. PubMed ID: 36684288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning.
    Huang M; Zhang Y; Ou X; Wang C; Wang X; Qin B; Zhang Q; Yu J; Zhang J; Yu J
    J Oncol; 2021; 2021():6173206. PubMed ID: 34394351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization and Clinical Characteristics of m5C-Based RNA Methylation in Spinal Cord Injury: Validated by qPCR.
    Cao L; Pi WJ; Zhang Q; Li Q
    Int J Genomics; 2022; 2022():5433860. PubMed ID: 36582430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer.
    Song L; Wang S; Li Q; Lu Y; Yang R; Feng X
    J Oncol; 2023; 2023():9931419. PubMed ID: 36936373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Infiltrates of m5C RNA Methylation-Related LncRNAs in Uterine Corpus Endometrial Carcinoma.
    Gu WX; Chen Y; Wang W
    J Oncol; 2022; 2022():1531474. PubMed ID: 35392434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA Methylation Modification 5-Methylcytosine Impacts Immunity Characteristics, Prognosis and Progression of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Gao L; Chen R; Sugimoto M; Mizuta M; Zhou L; Kishimoto Y; Huang X; Omori K
    Front Bioeng Biotechnol; 2021; 9():760724. PubMed ID: 34957065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.